Dr. Katayoon Goodarzi, MD

Dr. Goodarzi practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Goodarzi's NPI, 1518073345, was assigned on August 22, 2006. Dr. Goodarzi graduated from Albert Einstein College of Medicine of Yeshiva University in 1995. Dr. Goodarzi holds Massachusetts license 157876.

Dr. Goodarzi's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Dr. Goodarzi's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Goodarzi is also affiliated with Brigham and Women's Hospital. The medical group on file is Massachusetts General Hospital. Dmand AI also links Dr. Goodarzi to 3 more hospitals, 6 medical groups and 1 community health center, each named with a free account. Dr. Goodarzi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goodarzi practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Goodarzi's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Goodarzi is licensed in Massachusetts.

CMS data shows 496 Medicare services from Dr. Goodarzi across 4 procedure codes in 2024, for 209 Medicare patients. Medicare paid $45,933 for them.

CMS counts 209 Medicare patients who saw Dr. Goodarzi in 2024. The largest group is 65 to 74, with 87 patients. 73% of them have high cholesterol, and 64% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goodarzi's median patient age at 73, with 54% women.

In 2024, Dr. Goodarzi wrote 181 Medicare Part D claims for 56 patients. 44% of them were for generic drugs. CMS names the drug for 163 of them, across 3 drugs with 11 or more claims each, at $121,543 in total drug cost. In 2023, CMS named 150 claims across 3 drugs.

Dr. Goodarzi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Goodarzi as offering telehealth.

Dmand AI links 14 papers to Dr. Goodarzi, published from 2015 to 2023. 2022 was the busiest year, with 3. The most frequent topics are Thrombocytopenia, Recombinant Fusion Proteins and Thrombopoietin. Dr. Goodarzi has published most often in Am J Hematol. Dr. Goodarzi's most frequent co-authors are David John Kuter, MD, Hanny Toban Al-Samkari, MD and Rachel P. Rosovsky, MD.

Dr. Goodarzi graduated from Albert Einstein College of Medicine of Yeshiva University in 1995.